These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 31462535

  • 1. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.
    Yang Y, Chung MR, Zhou S, Gong X, Xu H, Hong Y, Jin A, Huang X, Zou W, Dai Q, Jiang L.
    J Biol Chem; 2019 Oct 18; 294(42):15395-15407. PubMed ID: 31462535
    [Abstract] [Full Text] [Related]

  • 2. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
    Chen W, Zhu G, Tang J, Zhou HD, Li YP.
    J Pathol; 2018 Mar 18; 244(3):271-282. PubMed ID: 29083488
    [Abstract] [Full Text] [Related]

  • 3. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
    Cong F, Liu J, Wang C, Yuan Z, Bi L, Liang J, Su K, Qiu Y, Song T, Fan J, Chao G.
    Biomed Pharmacother; 2017 Aug 18; 92():927-934. PubMed ID: 28605877
    [Abstract] [Full Text] [Related]

  • 4. Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model.
    Yang Y, Chen Q, Zhou S, Gong X, Xu H, Hong Y, Dai Q, Jiang L.
    J Vis Exp; 2020 Jul 03; (161):. PubMed ID: 32716374
    [Abstract] [Full Text] [Related]

  • 5. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y, Ninomiya K, Miyamoto H, Sakamoto A, Iwasaki R, Hoshi H, Miyamoto K, Hao W, Yoshida S, Morioka H, Chiba K, Kato S, Tokuhisa T, Saitou M, Toyama Y, Suda T, Miyamoto T.
    J Exp Med; 2010 Apr 12; 207(4):751-62. PubMed ID: 20368579
    [Abstract] [Full Text] [Related]

  • 6. NADPH oxidase gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1.
    Kang IS, Kim C.
    Sci Rep; 2016 Nov 29; 6():38014. PubMed ID: 27897222
    [Abstract] [Full Text] [Related]

  • 7. Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss.
    Tran PT, Park DH, Kim O, Kwon SH, Min BS, Lee JH.
    Int J Mol Med; 2018 Jul 29; 42(1):569-578. PubMed ID: 29693149
    [Abstract] [Full Text] [Related]

  • 8. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
    Ozaki K, Yamada T, Horie T, Ishizaki A, Hiraiwa M, Iezaki T, Park G, Fukasawa K, Kamada H, Tokumura K, Motono M, Kaneda K, Ogawa K, Ochi H, Sato S, Kobayashi Y, Shi YB, Taylor PM, Hinoi E.
    Sci Signal; 2019 Jul 09; 12(589):. PubMed ID: 31289211
    [Abstract] [Full Text] [Related]

  • 9. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH, Kim JY, Baek JM, Ahn SJ, Jun HY, Erkhembaatar M, Kim MS, Lee MS, Oh J.
    J Bone Miner Res; 2016 Feb 09; 31(2):403-15. PubMed ID: 26255791
    [Abstract] [Full Text] [Related]

  • 10. The G9a histone methyltransferase represses osteoclastogenesis and bone resorption by regulating NFATc1 function.
    Komatsu K, Ideno H, Nakashima K, Udagawa N, Kobayashi Y, Kimura H, Tachibana M, Yamashita T, Nifuji A.
    FASEB J; 2024 Jul 15; 38(13):e23779. PubMed ID: 38967255
    [Abstract] [Full Text] [Related]

  • 11. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis.
    Li CH, Zhao JX, Sun L, Yao ZQ, Deng XL, Liu R, Liu XY.
    Biochem Biophys Res Commun; 2013 Jun 14; 435(4):533-9. PubMed ID: 23665018
    [Abstract] [Full Text] [Related]

  • 12. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
    Jeong BC, Kim JH, Kim K, Kim I, Seong S, Kim N.
    Bone; 2017 Feb 14; 95():33-40. PubMed ID: 27829167
    [Abstract] [Full Text] [Related]

  • 13. Constitutive Activation of β-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice.
    Sui X, Deng S, Liu M, Fan L, Wang Y, Xu H, Sun Y, Kishen A, Zhang Q.
    Cell Physiol Biochem; 2018 Feb 14; 48(5):2091-2102. PubMed ID: 30107384
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional Modulator Ifrd1 Regulates Osteoclast Differentiation through Enhancing the NF-κB/NFATc1 Pathway.
    Iezaki T, Fukasawa K, Park G, Horie T, Kanayama T, Ozaki K, Onishi Y, Takahata Y, Nakamura Y, Takarada T, Yoneda Y, Nakamura T, Vacher J, Hinoi E.
    Mol Cell Biol; 2016 Oct 01; 36(19):2451-63. PubMed ID: 27381458
    [Abstract] [Full Text] [Related]

  • 15. mTORC1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice.
    Zhang Y, Xu S, Li K, Tan K, Liang K, Wang J, Shen J, Zou W, Hu L, Cai D, Ding C, Li M, Xiao G, Liu B, Liu A, Bai X.
    J Bone Miner Res; 2017 Sep 01; 32(9):1829-1840. PubMed ID: 28520214
    [Abstract] [Full Text] [Related]

  • 16. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.
    Biochem Pharmacol; 2013 Sep 15; 86(6):782-90. PubMed ID: 23928189
    [Abstract] [Full Text] [Related]

  • 17. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
    Zhang Z, Wen H, Yang X, Zhang K, He B, Zhang X, Kong L.
    Curr Stem Cell Res Ther; 2019 Sep 15; 14(3):239-243. PubMed ID: 30516111
    [Abstract] [Full Text] [Related]

  • 18. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM, Lee JH, Lee GS, Noh EM, Song HK, Gu DR, Kim SC, Lee SH, Kwon KB, Lee YR.
    BMC Complement Altern Med; 2017 Mar 23; 17(1):164. PubMed ID: 28335757
    [Abstract] [Full Text] [Related]

  • 19. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY, Lee KH, Kim YK.
    Int J Mol Med; 2018 Jul 23; 42(1):331-345. PubMed ID: 29620250
    [Abstract] [Full Text] [Related]

  • 20. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH, Darvin P, Kang DY, Sp N, Byun HJ, Lee CH, Lee HK, Yang YM.
    PLoS One; 2016 Jul 23; 11(7):e0159891. PubMed ID: 27447722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.